Dunhill Financial’s CareDx CDNA Stock Holding History

Dunhill Financial’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50	Closed	-$727	–	2024
2025 Q3	$727	Hold	50	–	–	﹤0.01%	803
2025 Q2	$977	Hold	50	–	–	﹤0.01%	777
2025 Q1	$888	Hold	50	–	–	﹤0.01%	807
2024 Q4	$1.07K	Buy	+50	New	+$1.22K	﹤0.01%	747

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Dunhill Financial's CDNA Position: Q4 2025 in Review

Dunhill Financial sold out of CareDx (CDNA) in Q4 2025, closing a stake of 50 shares — an estimated $727 sold.

Dunhill Financial first reported a position in CDNA in Q4 2024 and held it in 4 quarters. The position peaked at $1.07K in Q4 2024. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

Dunhill Financial reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
Dunhill Financial sold 50 CareDx shares in Q4 2025, an estimated $727.
Dunhill Financial first reported a position in CareDx in Q4 2024 and held it in 4 quarters.
Dunhill Financial's CareDx position peaked at $1.07K in Q4 2024.
200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on Dunhill Financial's 13F filing for Q4 2025, filed 29 Jan 2026.